Detailed disclosure is attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gujarat Terce Laboratories reported annual revenue of Rs 4,747.27 lakh for FY26, down from Rs 5,019.52 lakh in FY25, representing a revenue decline of about 5.4%. Despite lower revenue, the company turned profitable with PAT of Rs 220.17 lakh compared to a loss of Rs 97.87 lakh in the previous year. An exceptional charge of Rs 45.39 lakh was recorded due to a one-time provision for employee benefits following new Labour Codes. The statutory auditor issued an unmodified (clean) opinion. The Board also re-appointed Mr. Aalap Prajapati as Managing Director & CEO for 5 years from October 2026.
The stock shows improved profitability despite revenue decline, indicating better cost management. The clean audit opinion removes going concern concerns. The exceptional item is non-recurring and should not impact future earnings.